Status:
UNKNOWN
Beta Carotene From Natural Source for Patients With Non-Active Crohn's Disease
Lead Sponsor:
Bnai Zion Medical Center
Conditions:
Crohn's Disease
Eligibility:
All Genders
17-75 years
Phase:
PHASE3
Brief Summary
Many inflammatory disorders in the body are linked to oxidative tissue damage. Anti-oxidants that are present in many natural food sources may provide protection from such damage. Beta carotene is an...
Detailed Description
Patients with documented Crohn's disease who are at least 2 months in remission (CDAI\<150) will be randomized to receive 60 mg beta carotene/day vs. placebo for 1 year. The study medication will be ...
Eligibility Criteria
Inclusion
- patients with documented Crohn's disease in remission (CDAI\<150) for at least two months, age 17-75 years
Exclusion
- active Crohn's disease (CDAI\>150), partial bowel obstruction, impending surgery, pregnancy, serious other diseases
Key Trial Info
Start Date :
July 1 2002
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00275418
Start Date
July 1 2002
Last Update
January 12 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bnai Zion Medical Center
Haifa, Israel, 31048